Axcelis Technologies, Inc. — Q3 2015 Form 10-Q
Business and period: Axcelis makes ion implantation and other semiconductor-fabrication equipment and provides related aftermarket services. This unaudited report covers the quarter and nine months ended September 30, 2015; comparisons are with the same 2014 periods. Amounts below are in U.S. dollars.
Financial performance
| Metric | Q3 2015 | Q3 2014 | Nine months 2015 | Nine months 2014 |
|---|---|---|---|---|
| Revenue | $79.3 million | $38.5 million | $231.0 million | $140.5 million |
| Gross profit / margin | $29.2 million / 36.8% | $15.1 million / 39.3% | $79.7 million / 34.5% | $51.4 million / 36.6% |
| Operating income (loss) | $7.7 million | $(5.4) million | $18.3 million | $(11.1) million |
| Net income (loss) | $6.1 million | $(4.7) million | $13.9 million | $(11.4) million |
| Diluted earnings (loss) per share | $0.05 | $(0.04) | $0.11 | $(0.10) |
- Revenue mix and growth: Product revenue rose 128% in Q3 and 75% for the nine-month period, primarily on higher Purion system sales. Systems revenue was $47.0 million in Q3 and $131.1 million year to date. Services revenue declined 10.5% in Q3 and 7.6% year to date.
- Margins and expenses: Gross margin fell year over year, chiefly because new Purion systems carried lower initial margins; product-margin pressure also reflected a lower mix of higher-margin parts and upgrades. Operating expenses were $21.5 million in Q3 and $61.4 million year to date. Prior-year restructuring charges were largely absent in 2015.
- Cash flow: For the nine months, operating activities generated $12.4 million, versus $13.8 million used in 2014. Investing activities used $1.3 million, mainly for capital expenditures. Financing activities provided $37.7 million, including headquarters sale-leaseback proceeds.
- Liquidity and obligations: At September 30, cash and cash equivalents were $79.9 million; current assets were $248.6 million and current liabilities $49.8 million. The former $14.5 million term loan was repaid. A $47.6 million sale-leaseback financing obligation was recorded as long term. Contractual lease payments total $131.9 million over the 22-year term, including interest. The revolving credit facility had $3.1 million of available capacity at quarter-end and was terminated in October 2015; outstanding letters of credit were then cash-collateralized.
Changes, outlook, and risks
- Management attributed system growth to Purion market-share gains and an improved semiconductor equipment market. It expects continued Purion system growth and tight cost control; the filing gives no quantified revenue or earnings guidance.
- The January 2015 headquarters sale generated $48.9 million in proceeds but was accounted for as a financing arrangement because of continuing involvement. The 22-year lease has initial annual rent of $4.7 million, rising to $7.3 million in year 22; the stated implied interest rate is 10.65%.
- Customer concentration is significant: the ten largest customers generated 77.9% of nine-month revenue; one customer represented 33.0%. Two customers represented 32.8% and 16.1% of Q3 revenue.
- Management said existing cash and cash equivalents, together with forecasts, should cover anticipated short- and long-term requirements. It cautioned that liquidity and results depend on customer acceptance, semiconductor-fabrication activity, competition and pricing, production costs, and global economic, political, and financial conditions.
- The company maintains a full valuation allowance against U.S. deferred tax assets of approximately $140 million, citing a three-year cumulative U.S. loss position. Management reported no litigation it believed would materially adversely affect operations, no material change in disclosed risk factors, and effective disclosure controls.
Investor verification points
- Assess whether Purion system growth and market-share gains are sustainable, and whether lower initial system margins improve with product maturity.
- Review customer concentration, order timing, and customer acceptance-related deferred revenue.
- Examine the economics, cash collateral requirements, and long-term obligations of the headquarters sale-leaseback, including the post-quarter credit-facility termination.
- Track inventory growth, warranty accruals, and operating cash conversion as sales expand.
- Evaluate exposure to semiconductor-equipment cyclicality, competitive pricing, foreign exchange, and the conditions required to use deferred tax assets.